Previous Article | Next Article ![]()
Molecular and Cellular Biology, September 2006, p. 6598-6608, Vol. 26, No. 17
0270-7306/06/$08.00+0 doi:10.1128/MCB.00241-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Chun-Yuan Ting,1,
Guilherme Neves,2
Kimberly Hung,1
Shu-ning Hsu,3
Akira Chiba,3
Andrew Chess,2 and
Chi-Hon Lee1*
Unit on Neuronal Connectivity, Laboratory of Gene Regulation and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892,1 Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114,2 Department of Cell and Structure Biology, University of Illinois, Urbana, Illinois 618013
Received 8 February 2006/ Returned for modification 27 March 2006/ Accepted 16 June 2006
|
|
|---|
|
|
|---|
The Drosophila CadN gene contains three modules of alternative exons and undergoes alternative splicing to generate 12 isoforms. Although complex alternative splicing is not unusual for transcription factors and ion channels, it has been reported for only a small number of genes encoding surface receptors (30, 39). Among these are the vertebrate neurexins and insect Dscam (Down syndrome cell adhesion molecule), which can generate more than 1,000 and 38,000 isoforms, respectively (16, 29). In addition, the vertebrate cadherin-related neuronal receptor (CNR) genes utilize different promoters to generate approximately 50 isoforms (8, 45, 46). Though these findings suggest that alternative splicing in these receptor genes could conceivably generate extensive molecular complexity on the cell surfaces, the functions of receptor diversity are just being elucidated (30). Single-cell transcript analyses showed that individual Purkinje cells expressed different sets of CNR isoforms in mice (6), and individual photoreceptor neurons express different subsets of Dscam isoforms in flies (20). Furthermore, Dscam isoforms mediate strong homophilic but not heterophilic interactions (44). By expressing a distinct subset of Dscam or CNR isoforms, individual neurons could carry a unique combination of molecular tags or a unique identity, which would facilitate neuron-target or neuron-self recognition. Interestingly, vertebrate Dscam and CadN and insect neurexin do not appear to undergo extensive alternative splicing (32). It is likely that arthropods and vertebrates each selected different surface receptors to expand their repertoires during evolution.
The modular organization, and likely alternative splicing, of the CadN gene are conserved in Arthropoda, including mosquitoes and beetles (21, 37). Their conservation over 380 million years of evolutionary time is not restricted to the genomic structure but is extended to the amino acid sequence level, suggesting functional significance. All CadN isoforms generated by alternative splicing share the same molecular architecture but have different sequences in their extracellular and transmembrane domains. Although the differences in sequence in CadN isoforms could conceivably result in distinct properties, previous studies have not revealed any isoform specificity. Using the Drosophila visual and olfactory systems as models, previous studies showed that expression of a single CadN isoform is sufficient to rescue the CadN axonal-mistargeting phenotypes (19, 25, 37, 48). Furthermore, an in vitro cell aggregation study revealed that CadN isoforms mediate promiscuous heterophilic interactions (37). Thus, the functions of CadN molecular diversity remain to be determined.
In this study, we investigate the function of CadN molecular diversity. We find that the alternative splicing of CadN is regulated in a developmental, but not a cell-type-specific, fashion. In addition, CadN isoforms mediate graded homophilic interactions. We propose that CadN isoforms are differentially expressed during different developmental stages to provide adhesive interactions of different strengths.
|
|
|---|
Real-time PCR.
Primers and TaqMan probes were designed using PrimerExpress 1.0 software (PerkinElmer Life Sciences). Each assay was designed to detect one specific alternative exon and contained one general primer and one exon-specific primer to amplify 100 to 150 bp of the CadN transcript. To increase specificity, the designed TaqMan probes encompassed the junction sequence between the alternative and common exons (see Table 1 for primer sequences). TaqMan probes, primers, and universal TaqMan master mix were obtained from Applied Biosystems and used according to the manufacturer's instructions. An ABI Prism 7000 sequence detection system was used for real-time PCR analyses. Controlled amounts (10 to 3000 fg) of CadN isoform cDNAs were used as templates to derive standard curve and PCR efficiency and to test cross-reactivity for each assay. To construct the standard curve for the internal control, 18S rRNA, we used 10 to 1000 fg of the cDNAs from the 12-h and 24-h embryonic stages. The following thermocycling program was used for PCR amplification: one cycle at 50°C for 2 min and 95°C for 10 min and 50 cycles at 95°C for 15 s and 60°C for 1 min. Experiments were performed in triplicate. The data were analyzed using ABI Prism 7000 sequence detection system software. The standard errors of the ratio {SE[a/(a + b)]} were calculated using the
method (26) with the following formulation: SE[a/(a + b)] = [ûb2 x
a2/(ûa + ûb)4 + µa2 x
b2/(ûa + ûb)4]1/2, where û and
are the sample mean and standard error, respectively. The primers and TaqMan probes used for real-time PCR are listed in Table 1.
|
View this table: [in a new window] |
TABLE 1. Primers and TaqMan probes used for real-time PCR
|
![]() View larger version (36K): [in a new window] |
FIG. 1. Exon organization of the Drosophila CadN gene. The CadN gene contains three exon modules corresponding to exons 7 (7a, 7a',7b), 13 (13a, 13b), and 18 (18a, 18b) (37). Mutually exclusive alternative splicing results in variable transcripts that encode 12 different isoforms, each sharing the same molecular architecture but having different sequences in their cadherin repeats (exons 7 and 13) or EGF-CA repeats and transmembrane domains (exons 18a and 18b). Amino acid sequences encoded by the alternative exons 18a and 18b are shown with the conserved residues colored red and the divergent residues blue or brown. The putative "AXXXG" motif in the transmembrane domain encoded by the exon 18b is marked with yellow plus signs. Constant exons are shown as orange boxes and alternative exons as green or blue boxes. SP, signal peptide; CA, cadherin repeat; NC, nonchordate domain; EGF, EGF-like calcium-binding repeat; LamG, laminin-G-like domain; TM, transmembrane domain; JX, juxtamembrane region; ßcat, ß-catenin binding region; cleavage, proteolytic cleavage site.
|
FACS analysis. Cells were fixed for 10 min with 1% paraformaldehyde in phosphate-buffered saline (PBS) at room temperature. For surface fluorescence-activated-cell-sorter (FACS) analysis, cells were fixed, labeled using a Rat monoclonal antibody against the CadN extracellular domain [anti-CadN(EX), a gift from Tadashi Uemura] in a nondetergent buffer (5% goat serum in PBS), and then washed with this buffer before being labeling with Alexa 647-conjugated anti-rat immunoglobulin G secondary antibody and propidium iodide (PI). For GFP FACS analysis, cells were directly stained with a fluorescein isothiocyanate-conjugated anti-GFP antibody in a wash buffer (5% goat serum, 0.1% Triton X-100 in PBS) and then washed with the washing buffer to remove unbound antibodies. Cells were treated with RNase in PBS for 30 min at 37°C and then stained with PI for 20 min at room temperature. CadN expression, GFP, and DNA content (PI signal) were measured using a FACSCalibur flow cytometer (Becton Dickinson) with the appropriate filter sets. For each sample, 10,000 cells were analyzed. Data acquisition and analysis were performed using CELLQuest software (Becton Dickinson).
Immunoprecipitation and Western blotting. Cell lysis, immunoprecipitation, and immunoblotting were performed as previously described (3), except that we used a different lysis buffer (50 mM Tris-Cl [pH 7.4], 150 mM NaCl, 1 mM dithiothreitol (DTT), and 1% NP-40 with or without 5 mM CaCl2). For each lane, a protein sample equivalent to 200,000 S2 cells was loaded. Rat monoclonal antibody against the cytoplasmic domain of CadN proteins (a gift from Tadashi Uemura) and rabbit polyclonal anti-GFP antibody (Molecular Probe) were used to detect the CadN and CadN-GFP fusion proteins, respectively.
|
|
|---|
![]() View larger version (21K): [in a new window] |
FIG. 2. TaqMan-based real-time PCR analysis provides an accurate measurement of the expression levels of the CadN alternative exons. (A) A schematic for primer and probe design is shown for exons 18a and 18b. Each assay used one alternative-exon-specific probe (blue or green line), one alternative-exon-specific primer (blue or green arrow), and one common primer (black arrows). In order to ensure target specificity, the TaqMan probes were designed to match the exon-exon boundary. Common exons 17 and 19 are shown in pink boxes, and alternative exons 18a and 18b in a blue or green box, respectively. (B to D). Standard curves and cross-reactivity tests for exons 7a/7b, 13a/13b, and 18a/18b, respectively. The accuracy and specificity of the TaqMan probes were tested using the cDNAs of the CadN isoform 7b-13a-18a or 7a-13b-18b in control amounts (as indicated). The x axis represents the logarithm of the input cDNA; the y axis represents the number of PCR cycles required to reach a given fluorescent signal level (Ct). When the probes were tested against their cognate target cDNAs (blue rhomboids and red squares), an inverse linear relationship between Ct and the logarithm of the input cDNA was observed over a range of 10 to 3,000 fg of CadN cDNA. Cross-reactivity, tested using TaqMan probes with their noncognate targets (blue discs and red triangles), was found to be minimal. Standard linear regression analysis was performed to calculate the standard curve, the coefficient of determination (R2), and PCR efficiency (E) (as indicated). The standard curves were used to calculate the experimental data (Fig. 3) by interpolation. (E) The standard curve for the internal control, 18S rRNA. Experiments were performed as for panels A to C except that embryo cDNAs were used as the target. (F) The CadN expression levels at different developmental stages were normalized using 18S rRNA as an internal reference (E). The sums of the expression levels of the CadN alternative exons 7a/7b, 13a/13b, and 18a/18b are shown as red, blue, and yellow bars, respectively. The x axis represents the developmental stages; the y axis represents CadN expression levels in an arbitrary unit (A.U.) with respect to the 18S rRNA level in the same sample.
|
CadN alternative splicing is regulated in a temporal fashion during development. We first used this assay to determine the CadN isoform expression profiles in whole animals at different developmental stages. We found that all six alternative exons are expressed at some level throughout development (Fig. 3A). However, there were several significant differences in the CadN expression profiles at different developmental stages, indicating that CadN alternative splicing is developmentally regulated. At the early embryonic stage (Fig. 3A), exons 7a and 18b were predominantly used (88.3% and 94.8%, respectively) while exons 13a and 13b were expressed at approximately equal levels. In sharp contrast, at the late embryonic stage, exons 7b, 13a, and 18a (Fig. 3A) are used predominantly (89.7%, 94.7%, and 74.1%, respectively). Moreover, from the larval to pupal stages (Fig. 3A), the relative levels of 7b, 13a, and 18a gradually increased, and in the adult stage they constituted more than 90% of the total CadN transcripts (90.0%, 93.6%, and 94.7%, respectively). These data indicate that the isoform 7b-13a-18a is prevalent in the adult stage, while the other isoforms encoded by exons 7a, 13b, and 18b are expressed primarily during development.
![]() View larger version (35K): [in a new window] |
FIG. 3. CadN alternative splicing is developmentally regulated. The expression profiles of CadN alternative exons in wild-type animals were examined with TaqMan real-time PCR. The expression levels of alternative exons are described as percentages of the total CadN transcript levels. (A) CadN expression profiles of whole animals were assessed at the following five developmental stages: early embryo (embryos collected 0 to 12 h after egg laying), late embryo (embryos collected 12 to 24 h after egg laying), third larvae (wandering third instar larvae), pupae (20 to 80 h after pupal formation), and adult (heads of 1- to 3-day-old adult flies). (B) CadN expression profiles of different tissues of third instar larvae. The third larvae is as described for panel A; the antenna disc, brain, and eye disc are as indicated. (C) CadN expression profiles of the eye discs at the five different developmental stages, as indicated. (D) CadN expression profiles were assessed in two R-cell populations, R3/4 and R7 neurons, and in eye discs as described for panel B. All data present means and standard errors (error bars) of triplicate samples.
|
We next examined CadN isoform profiles in the retina at different developmental stages. As in embryos, similar changes in the CadN expression profiles of the developing eye discs were observed for exons 18a and 18b: from the third instar larval, to the pupal, to the adult stages, the exon 18a level gradually increased from 15% to 92% (Fig. 3C). The 7b-13a-18b and 7b-13a-18a isoforms were the predominant forms in the larval eye discs and in the adult eyes, respectively; however, these two forms were expressed at similar levels during the pupal stages. Unlike that in the embryos, levels of exons 7a/b and 13a/b remain largely unchanged in developing retina.
We next examined whether different subtypes of photoreceptor neurons express different isoforms. Using a previously established cell-sorting method (20), we isolated R3/4 and R7 neurons from the third instar larval eye discs (see Fig. S1 in the supplemental material) and subjected the extracted RNA to quantitative PCR analyses. We found little difference between the expression profiles of the two R-cell types: R3/4 and R7 neurons exhibited virtually identical expression profiles on exons 7a/7b and 18a/18b and a similar preference for exon 13a over 13b (Fig. 3D). In summary, the alternative splicing of exons 18a/18b, but not of the other alternative exons, is dynamically regulated in the developing eye discs. However, the R3/4 and R7 types of photoreceptor neurons have similar expression profiles.
CadN isoforms mediate graded homophilic interactions. The developmental regulation of CadN alternative splicing suggests that the isoforms might be differentially expressed to serve different functions if they have different biological activities. The CadN 7b-13a-18a isoform has been reported to mediate homophilic interaction in an S2 cell-based cell aggregation assay (12). The CadN isoforms have different amino acid sequences in their extracellular and transmembrane domains (Fig. 1), which could potentially alter their binding activities. Therefore, we set up a quantitative cell aggregation assay to measure the adhesive activity of different CadN isoforms.
We found that S2 cells expressing the CadN 7b-13a-18a isoform or the alternative exon-substituted isoforms 7a-13a-18a, 7b-13b-18a, and 7b-13a-18b formed aggregates in the presence of calcium, indicating that they mediate homophilic interactions (Fig. 4C to F). The sizes of the cell aggregates varied significantly, depending on the specific CadN isoform the S2 cells expressed. The protein expression levels of different CadN isoforms, assayed by Western blotting, were comparable (Fig. 5A). Furthermore, FACS analysis using an antibody against the CadN extracellular domain revealed that the surface expression profiles of the CadN 7b-13a-18a and 7b-13a-18b isoforms were indistinguishable (Fig. 5B to E). The data indicated that the observed differences in the aggregate sizes were due to the intrinsic properties of different CadN isoforms rather than differences in their expression levels or surface presentations. We quantified the sizes of the cell aggregates by counting the number of S2 cells in each aggregate (Fig. 4G; see Materials and Methods for details). We observed that the CadN 7b-13a-18b isoform was capable of inducing very large aggregates, while the 7b-13a-18a isoform induced mostly small ones (P < 0.005). It is likely that the 18b-type CadN's ability to induce larger cell aggregates reflects its stronger adhesive activity (or avidity) or faster forward-binding kinetics than that of the 18a type.
![]() View larger version (31K): [in a new window] |
FIG. 4. CadN isoforms mediate graded homophilic interactions. S2 cells coexpressing a GFP marker and CadE (E-cadherin) or different CadN isoforms were assessed for their abilities to induce cell aggregation (see Materials and Methods for details). (A to F). Representative images of cell aggregates induced by the expression of CadN isoforms or CadE and the addition of 10 mM of calcium. (A) GFP as a negative control; (B) CadE as a positive control; (C to F) CadN isoforms as indicated. Scale bar: 100 µm. (G) A bar chart of the size of cell aggregates formed by S2 cells expressing different CadN isoforms in the presence of 5 (striped bars) or 10 (solid bars) mM of calcium. Cell aggregates are divided into five categories according to the number of cells in each aggregate. The x axis represents the cell aggregate size (25 to 50, 50 to 100, 100 to 150, 150 to 200, and greater than 200 cells per cell cluster). The y axis represents the total number of cells that form a given range of cell cluster size. The bars indicate the means of three independent results. The error bars indicate the standard error. *, P < 0.005.
|
![]() View larger version (26K): [in a new window] |
FIG. 5. CadN isoforms exhibit similar surface representations. (A) Western blot analysis of the S2 cells expressing CadN 7b-13a-18a (lane 1), CadN 7a-13a-18a (lane 2), CadN 7b-13b-18a (lane 3), CadN 7b-13a-18b (lane 4), and GFP (lane 5). Rat monoclonal antibodies against the intracellular domain of the CadN protein were used to quantify the CadN expression. Mature CadN protein is proteolytically cleaved in the extracellular domain (Fig. 1) (12), resulting in two fragments that are associated noncovalently. Double and single asterisks indicate the unprocessed form and the processed C-terminal fragment of CadN proteins, respectively. M, molecular mass markers. (B to E) The surface expression of CadN isoforms was assessed using surface FACS (S-FACS) analysis. Anti-CadN (EX) antibody, which recognizes the extracellular domain of CadN, was used to label CadN protein on cell surfaces under non-cell-permeation conditions (see Materials and Methods for details). (B to D) Scatter plots of S-FACS analyses of the control S2 cells (B), the S2 cells expressing CadN 7b-13a-18a (C), and the CadN 7b-13a-18b isoform (D). The x axis represents the CadN surface expression level; the y axis represents the PI signal for the DNA content. S2 cells are heterogeneous, and large polyploid cells exhibit a low level of autofluorescence. The gate (boxed area) was established to exclude these cells in the analyses. For each sample, 10,000 cells were analyzed. The CadN 7b-13a-18a (C) and CadN 7b-13a-18b isoforms (D) were expressed by 13.2% and 12.8%, respectively, of S2 cells. (E) A histogram showing the CadN-positive cells in the gated area of panels C and D. The x axis represents CadN signal intensity; the y axis represents the cell number.
|
The transmembrane domain of CadN regulates its adhesive activity. Exons 18a and 18b each encode one and one-half EGF-like repeats and one half of the transmembrane domain (Fig. 1). To determine which of these regions is responsible for the differential adhesive activity between the exon 18a- and 18b-encoding isoforms, we conducted a domain-swapping experiment. Interestingly, the CadN chimera 7b-13a-EGF-CA(18a)-TM(18b) (which contains the transmembrane domain encoded by exon 18b but which is otherwise CadN 7b-13a-18a) induced large cell aggregates essentially indistinguishable from those induced by CadN 7b-13a-18b (Fig. 6D and E). Conversely, the chimera 7b-13a-EGF-CA(18b)-TM(18a) primarily induced small and intermediate-sized cell clusters (Fig. 6C and E). The overall expression levels (assayed by Western blotting) and the expression profiles at the individual cell level (assayed by FACS analysis) were indistinguishable in the four cell populations (see Fig. S3A to H in the supplemental material). These data support the role of transmembrane domains in regulating CadN-mediated adhesion.
![]() View larger version (28K): [in a new window] |
FIG. 6. The transmembrane domains of CadN isoforms determine the strength of the homophilic adhesive activity. Representative images of cell aggregates formed by the S2 cells expressing CadN 7b-13a-18a-GFP (A), CadN 7b-13a-18b-GFP (B), or the domain-swapped CadN, EGF-CA(18b)-TM(18a) (C) or EGF-CA(18a)-TM(18b) (D), in the presence of 10 mM of calcium. Scale bar in panel A, 100 µm. (E) Bar chart comparing the sizes of cell aggregates formed by S2 cells expressing different CadN isoforms in the presence of 5 (striped bars) or 10 (solid bars) mM of calcium. The cell aggregates were divided into five categories according to the number of cells in each aggregate. The x axis represents cell aggregate sizes 25 to 50, 50 to 100, 100 to 150, 150 to 200, and greater than 200 cells per cell cluster. The y axis represents the total number of cells that form a given range of cell cluster size. All data present means and standard errors (error bars) of triplicate samples. *, P < 0.005.
|
25% of GFP-CadN) coprecipitated with the GFP-tagged CadN, suggesting that they form cis homodimers or oligomers (Fig. 7, lane 1). The precipitation of native CadN depended on the presence of CadN-GFP, confirming the specificity of the immunoprecipitation (Fig. 7, lane 9). Furthermore, the formation of CadN cis homodimers (or oligomers) was largely dependent on calcium because only small amounts of CadN could be coimmunoprecipitated without calcium in the incubation and lysis buffers (Fig. 7, lane 3). To exclude the possibility that coimmunoprecipitation (co-IP) of CadN and CadN-GFP reflects trans interaction rather than cis interaction, we mixed two populations of S2 cells, one expressing the CadN native form and the other CadN-GFP, and performed immunoprecipitation in the presence of calcium as before. We found very little CadN (corresponding to
1% of CadN-GFP) coprecipitated with CadN-GFP (Fig. 7, lane 13), indicating that cis but not trans interaction is responsible for the observed co-IP. These data are consistent with a previous report that most of the trans interactions of cadherins are broken during immunoprecipitation processes (1).
![]() View larger version (71K): [in a new window] |
FIG. 7. CadN mediates calcium-dependent cis interactions. (A) CadN 7b-13a-18a and CadN 7b-13a-18a-GFP (lanes 1, 3, 5, and 7) or CadN 7b-13a-18b (lanes 2, 4, 6, and 8) and its GFP-tagged version were coexpressed in S2 cells. The association of CadN and CadN-GFP, in the presence (lanes 1, 2, 5, and 6) or absence (lanes 3, 4, 7, and 8) of 5 mM of calcium, was assessed by immunoprecipitation. Extracts (lanes 5 to 8) or anti-GFP immunoprecipitates (lanes 1 to 4) were analyzed by Western blotting and probed with an antibody recognizing the CadN cytoplasmic domain [ CadN (IN)]. CadN 7b-13a-18a (or CadN 7b-13a-18b) coimmunoprecipitated with CadN 7b-13a-18a-GFP (or CadN 7b-13a-18b-GFP) in the presence of calcium. In the absence of calcium, only a small fraction of CadN coimmunoprecipitated with CadN-GFP. Mature CadN protein is proteolytically cleaved to form N-terminal and C-terminal fragments (12). The C-terminal fragments of CadN ( 110 kDa) and CadN-GFP ( 140 kDa) are indicated by single and double plus signs, respectively. Some CadN protein remained unprocessed (asterisk). (B) In the absence of CadN-GFP, CadN 7b-13a-18a (lane 9) and CadN 7b-13a-18b (lane 10) were not found in the anti-GFP immunoprecipitates, indicating that the anti-GFP antibody is specific. Extracts of the S2 cells expressing CadN 7b-13a-18a (lane 11) or CadN 7b-13a-18b (lane 12) used for the immunoprecipitate experiments were analyzed with anti-CadN (IN) Western blotting. (C) trans interactions between CadN and CadN-GFP were assessed using anti-GFP immunoprecipitation (Ip). Two separate populations of S2 cells, one expressing CadN and the other CadN-GFP (7b-13a-18a, lanes 13 and 15; 7b-13a-18b, lanes 14 and 16), were mixed and subjected to anti-GFP Ip and Western blot analysis as described before. Only a very small amount of CadN coimmunoprecipitated with CadN-GFP, indicating that the trans association between CadN and CadN-GFP was largely disrupted by the experimental procedures.
|
|
|
|---|
Previous studies demonstrated that expression of a single CadN isoform is sufficient to rescue targeting defects in the CadN mutant photoreceptor and olfactory neurons (19, 25, 37, 48). While it is possible that in these transgene rescue experiments quantitative differences among the adhesive activities of CadN isoforms are masked by the artificially high expression levels mediated by transgenes, these results clearly establish that the CadN isoforms do not form synaptic codes to direct target selection in the visual and olfactory systems. This is further supported by our quantitative transcript analyses showing that different R-cell subtypes have similar CadN isoform expression profiles.
Interestingly, our quantitative transcript analyses revealed that CadN alternative splicing is developmentally regulated. Overall, the exon 18a-encoding CadN isoforms are primarily expressed during the late developmental and adult stages, while the exon 18b-encoding isoforms are expressed during the early developmental stage. In the retina, CadN 7b-13a-18b dominates during the third instar larval stage when R-cells project axons, and it gradually switches to 7b-13a-18a from the early pupal to the adult stages. This developmental switch from exon 18b to 18a is of particular interest in light of the observed differences in the adhesive activities of the isoforms encoded by these two exons. We hypothesize that 7b-13a-18b provides strong homophilic interactions among the axons during axon extension, while 7b-13a-18a mediates weak, and perhaps tunable, interactions between growth cones and their targets. It has been revealed that, in vertebrates, synaptic adhesion mediated by N-cadherin is modulated by synaptic activity (36). Therefore, the alternative hypothesis is that the high-affinity 18b-type isoforms are replaced with the low-affinity 18a type at the late developmental stage to ensure synaptic plasticity in the adults.
The transmembrane domain of CadN regulates adhesive activity. Using an in vitro cell aggregation assay to study CadN-mediated adhesion, we demonstrated that the S2 cells expressing the 18b-type CadN aggregate faster and form larger clusters than those expressing the 18a type do. Although it is tempting to directly translate these measurements into affinity and kinetic parameters, note that this widely used aggregation assay has two limitations. First, because the cells have only limited time to form aggregates, this and other similar in vitro adhesion assays are intrinsically biased toward fast-association events (5, 17). The in vitro conditions clearly do not reflect slow in vivo events such as cell sorting but perhaps mimic those of fast events, such as the interactions between nerve growth cones and their targets. During the establishment of neuronal connections, nerve growth cones project highly motile filopodia to interact with dynamic filopodium-like structures of the target cells (18, 27, 41). Second, the cell aggregation assay described in this study and another (24) does not depend on the cytoplasmic domain of cadherins and thus their interactions with catenins and the actin cytoskeleton (S. Yonekura and C.-H. Lee, unpublished observation). While many in vivo functions of cadherins depend on their abilities to bind catenin (24), some might not. In the Drosophila visual system, the cytoplasmic domain of CadN is not required for R7 growth cones to reach the target layer (a CadN-dependent process) (Yonekura and Lee, unpublished). Taken together, these findings indicate that the in vitro cell aggregation assay described here and elsewhere likely assesses cadherin's ability to initiate adhesion, an important attribute of cadherin function.
Using domain swap experiments, we demonstrate that the transmembrane domains of CadN isoforms regulate their adhesive activities. To our knowledge, this is the first report documenting that transmembrane domains regulate adhesion. It has been suggested that interactions between transmembrane domains stabilize homodimer formation of the epidermal growth factor receptor (ErbB1) and the erythropoietin receptor (4, 43). Several transmembrane domains, including that of ErbB1, form dimers in the absence of their extracellular domains (15), and the dimer formation involves a G(S/A)XXXG motif in which transmembrane helix interactions are mediated (28). Interestingly, the Drosophilia CadN exon 18b- but not 18a-encoding transmembrane region contains an AXXXG motif (Fig. 1), and CadN protein forms cis dimers in culture cells. In classic vertebrate cadherins, cis dimer formation is a prerequisite for generating the adhesive tetramers in trans (23, 38). It is tempting to speculate that Drosophila CadN functions in a similar fashion. However, our co-IP experiment failed to reveal any differences in the abilities of exon 18a- and 18b-encoding CadN isoforms to form cis dimers. While it is possible that our co-IP assay was not sensitive enough to reveal the differences, the alternative explanation is that exon 18b-encoding transmembrane domains align the CadN in an orientation that facilitates trans-tetramer formation. The current study suggests that the cis interaction between the transmembrane domains could potentially modulate CadN avidity. Further experiments will be needed to determine the structural basis of the cis-interaction by transmembrane sequences.
This work is supported by the Intramural Research Program of the NIH, National Institute of Child Health and Human Development (grant HD008748-03 to C.-H.L.) S.Y. is a fellow of the Japan Society for the Promotion of Science.
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
These authors contributed equally to this work. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»